Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells

Kidney International

Volumn 63, Issue 5, 2003, Pages 1881-1887

  Kobayashi, Shuzo ^a   Moriya, Hidekazu ^a   Aso, Kuniko ^a   Ohtake, Takayasu ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Atheroscrelosis; Erythropoetin; Hemodialysis; Intima media thickness; Rheology; Viscosity; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BETA 2 MICROGLOBULIN; CHOLESTEROL; ERYTHROPOIETIN; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; ARTERY INTIMA PROLIFERATION; ARTICLE; ARTIFICIAL KIDNEY; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BLOOD VISCOSITY; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; ERYTHROCYTE; FEMALE; FLOW KINETICS; HEMODIALYSIS; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037408287     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00920.x     Document Type: Article

References (26)

1. BECKER B, HIMMELEFARB J, HENRICH W, HAKIM R: Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-486, 1997
2. ISLAM KN, O'BYRNE D, DEVARAJ S, et al: Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 150:217-224, 2000
3. HAKIM R: A clinical implication of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
4. ODETTI P, GARIBALDI S, GURRERI G, et al: Protein oxidation in hemodialysis and kidney transplantation. Metabolism 45:1319-1322, 1996
5. GIRNDT M, LENGLER S, KAUL H, et al: Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 35:95-104, 2000
6. MIYAZAKI H, MATSUOKA H, ITABE H, et al: Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer. Circulation 101:1002-1006, 2000
7. MUNE M, YUKAWA S, KISHINO M, et al: Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int 56(Suppl 71):S126-S129, 1999
8. STENVINKEL P, HEIMBÜRGER O, PAULTRE F: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
9. MYDLIK M, DERZSIOVA K, RACZ O, et al: A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int 59 (Suppl 78):S144-S147, 2001
10. DAUGIRDAS J: Chronic hemodialysis prescription: A urea kinetic approach, in Handbook of Dialysis, edited by DAUGIRDAS J, ING T, Boston, Little, Brown, 1994, p 94
11. BURKE GL, EVANS GW, RILEY WA, et al: Arterial wall thickness is associated with prevalent cardiovascular disease in middle-age adults. The atherosclerosis risk in communities (ARIC) study. Stroke 26:386-391, 1995
12. CALZAVARA P, DE ANGELI S, GATTO C, et al: Morphologic evaluation of red blood cells using vitamin E-modified dialysis filters, in Contributions in Nephrology, Vitamin E-bonded membrane, volume 127, edited by RONCO C, LA GRECA G, Basel, Karger, 1999, pp 172-176
13. USBERTI M, BUFANCO G, LIMA G, et al: Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane, in Contributions in Nephrology, Vitamin E-bonded membrane, volume 127, edited by RONCO C, LA GRECA G, Basel, Karger, 1999, pp 208-214
14. HURAIB S, TANIMU D, SHAHEEN F, et al: Effect of vitamin E-modified dialyzers on dialyser clotting, erythropoietin and heparin dosage: A comparative crossover study. Am J Nephrol 20:364-368, 2000
15. SASAKI M, HOSOYA N, SARUHASHI M: Vitamin E modified cellulose membrane. Artif Organs 24:779-789, 2000
16. PANZETTA O, COMINACINI L, GARBIN U: Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration. Clin Nephrol 44:303-309, 1995
17. STEIN G, RICHTER G, FUNFSTUCK R, et al: Serum vitamin E levels in patients with chronic renal failure. Int J Artif Organs 6:285-287, 1983
18. HULTQVIST M, HEGBRANT J, NILSON THORELL C, LINDHOLM T: Plasma concentrations of vit C, E and MDA during hemodialysis. Clin Nephrol 47:37-46, 1997
19. REGNSTROM J, NILSSON J, TORNVALL P, et al: Susceptibility to LDL oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186, 1992
20. SHIMAZU T, OMINATO M, TOYAMA K, et al: Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int 59(Suppl 78):S137-S143, 2001
21. TSURUOKA S, KAWAGUCHI A, NISHIKI K, et al: Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kid Dis 39:127-133, 2002
22. DHONDT A, VANHOLDER R, GLORIEUX G, et al: Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: Absence of an acute benefit on expression of leukocyte surface molecules. Am J Kid Dis 36:1140-1146, 2000
23. YAWATA Y, HOWE R, JACOB H: Abnormal red cell metabolism causing hemolysis in uremia. Ann Intern Med 79:362-367, 1973
24. GIARDINI O, TACCONE, GALLUCI M, LUBRANO R: Evidence of red blood cell membrane lipid peroxidation in hemodialysis patients. Nephron 36:235-237, 1984
25. PEUCHANT E, CARBONNEAU MA, DUBOURG L: Lipid peroxidation in plasma and red blood cells of patients undergoing hemodialysis: Vitamin A, E, and iron status. Free Radic Biol Med 16:339-346, 1994
26. TACCONE-GALLUCCI M, MELONI C, LUBRANO R, et al: Chronic hemolysis and erythrocyte survival in hemodialysis patients treated with vitamin E-modified dialysis filter, in Contributions in Nephrology, Vitamin E-bonded membrane, volume 127, edited by RONCO C, LA GRECA G, Basel, Karger, 1999, pp 44-48